465 related articles for article (PubMed ID: 29032282)
1. Atypical ductal hyperplasia: Our experience in the management and long term clinical follow-up in 71 patients.
Latronico A; Nicosia L; Faggian A; Abbate F; Penco S; Bozzini A; Cannataci C; Mazzarol G; Cassano E
Breast; 2018 Feb; 37():1-5. PubMed ID: 29032282
[TBL] [Abstract][Full Text] [Related]
2. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
3. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
Piubello Q; Montemezzi S; D'Atri C
Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
[TBL] [Abstract][Full Text] [Related]
4. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy.
Deshaies I; Provencher L; Jacob S; Côté G; Robert J; Desbiens C; Poirier B; Hogue JC; Vachon E; Diorio C
Breast; 2011 Feb; 20(1):50-5. PubMed ID: 20619647
[TBL] [Abstract][Full Text] [Related]
6. Breast carcinoma in sclerosing adenosis: a clinicopathological and immunophenotypical analysis on 206 lesions.
Yu BH; Tang SX; Xu XL; Cheng YF; Bi R; Shui RH; Tu XY; Lu HF; Zhou XY; Yang WT
J Clin Pathol; 2018 Jun; 71(6):546-553. PubMed ID: 29436376
[TBL] [Abstract][Full Text] [Related]
7. Atypical ductal hyperplasia on core biopsy: an automatic trigger for excisional biopsy?
McGhan LJ; Pockaj BA; Wasif N; Giurescu ME; McCullough AE; Gray RJ
Ann Surg Oncol; 2012 Oct; 19(10):3264-9. PubMed ID: 22878619
[TBL] [Abstract][Full Text] [Related]
8. Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: Report of a large multi-institutional series and review of the literature.
Foschini MP; Miglio R; Fiore R; Baldovini C; Castellano I; Callagy G; Bianchi S; Kaya H; Amendoeira I; Querzoli P; Poli F; Scatena C; Cordoba A; Pietribiasi F; Kovács A; Faistova H; Cserni G; Quinn C
Eur J Surg Oncol; 2019 Dec; 45(12):2279-2286. PubMed ID: 31301938
[TBL] [Abstract][Full Text] [Related]
9. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings.
Liberman L; Sama M; Susnik B; Rosen PP; LaTrenta LR; Morris EA; Abramson AF; Dershaw DD
AJR Am J Roentgenol; 1999 Aug; 173(2):291-9. PubMed ID: 10430122
[TBL] [Abstract][Full Text] [Related]
10. Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution.
Li X; Ma Z; Styblo TM; Arciero CA; Wang H; Cohen MA
Breast Cancer Res Treat; 2021 Feb; 185(3):573-581. PubMed ID: 33068196
[TBL] [Abstract][Full Text] [Related]
11. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
Renshaw AA; Derhagopian RP; Martinez P; Gould EW
Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
[TBL] [Abstract][Full Text] [Related]
12. Surgical and mammographic follow-up of papillary lesions and atypical lobular hyperplasia diagnosed with stereotactic vacuum-assisted biopsy.
Irfan K; Brem RF
Breast J; 2002; 8(4):230-3. PubMed ID: 12100116
[TBL] [Abstract][Full Text] [Related]
13. Flat epithelial atypia with and without atypical ductal hyperplasia: to re-excise or not. Results of a 5-year prospective study.
Uzoaru I; Morgan BR; Liu ZG; Bellafiore FJ; Gaudier FS; Lo JV; Pakzad K
Virchows Arch; 2012 Oct; 461(4):419-23. PubMed ID: 22961104
[TBL] [Abstract][Full Text] [Related]
14. Core Breast Biopsies Showing Lobular Carcinoma In Situ Should Be Excised and Surveillance Is Reasonable for Atypical Lobular Hyperplasia.
Sen LQ; Berg WA; Hooley RJ; Carter GJ; Desouki MM; Sumkin JH
AJR Am J Roentgenol; 2016 Nov; 207(5):1132-1145. PubMed ID: 27532153
[TBL] [Abstract][Full Text] [Related]
15. Atypical ductal hyperplasia in breast core needle biopsies. Correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow-up biopsies.
Renshaw AA; Cartagena N; Schenkman RH; Derhagopian RP; Gould EW
Am J Clin Pathol; 2001 Jul; 116(1):92-6. PubMed ID: 11447758
[TBL] [Abstract][Full Text] [Related]
16. Lobular neoplasia on core-needle biopsy--clinical significance.
Arpino G; Allred DC; Mohsin SK; Weiss HL; Conrow D; Elledge RM
Cancer; 2004 Jul; 101(2):242-50. PubMed ID: 15241819
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy.
Chae BJ; Lee A; Song BJ; Jung SS
World J Surg Oncol; 2009 Oct; 7():77. PubMed ID: 19852801
[TBL] [Abstract][Full Text] [Related]
18. Radiologic and Pathologic Features Associated With Upgrade of Atypical Ductal Hyperplasia at Surgical Excision.
Williams KE; Amin A; Hill J; Walter C; Inciardi M; Gatewood J; Redick M; Wick J; Hunt S; Winblad O
Acad Radiol; 2019 Jul; 26(7):893-899. PubMed ID: 30318287
[TBL] [Abstract][Full Text] [Related]
19. The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years.
Allen SD; Osin P; Nerurkar A
Eur J Surg Oncol; 2014 Jul; 40(7):824-9. PubMed ID: 24742589
[TBL] [Abstract][Full Text] [Related]
20. Isolated Atypical Lobular Hyperplasia Diagnosed on Breast Biopsy: Low Upgrade Rate on Subsequent Excision With Long-Term Follow-up.
Muller KE; Roberts E; Zhao L; Jorns JM
Arch Pathol Lab Med; 2018 Mar; 142(3):391-395. PubMed ID: 29160721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
